199 related articles for article (PubMed ID: 29967258)
1.
Li Y; Lin S; Li L; Tang Z; Hu Y; Ban X; Zeng T; Zhou Y; Zhu Y; Gao S; Deng W; Zhang X; Xie D; Yuan Y; Huang P; Li J; Cai Z; Guan XY
Cancer Res; 2018 Aug; 78(16):4471-4481. PubMed ID: 29967258
[TBL] [Abstract][Full Text] [Related]
2. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.
Huang W; Gao F; Li K; Wang W; Lai YR; Tang SH; Yang DH
World J Gastroenterol; 2015 Mar; 21(10):3055-65. PubMed ID: 25780306
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
Kanda M; Sugimoto H; Nomoto S; Oya H; Shimizu D; Takami H; Hashimoto R; Sonohara F; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Oncol; 2014 Nov; 45(5):2005-12. PubMed ID: 25189544
[TBL] [Abstract][Full Text] [Related]
4. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
5. PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB.
Zeng T; Tang Z; Liang L; Suo D; Li L; Li J; Yuan Y; Guan XY; Li Y
Mol Oncol; 2020 Dec; 14(12):3184-3197. PubMed ID: 33064899
[TBL] [Abstract][Full Text] [Related]
6. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
8. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
9. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
Zhang Z; Li TE; Chen M; Xu D; Zhu Y; Hu BY; Lin ZF; Pan JJ; Wang X; Wu C; Zheng Y; Lu L; Jia HL; Gao S; Dong QZ; Qin LX
Br J Cancer; 2020 Jan; 122(2):209-220. PubMed ID: 31819189
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human mitochondrial PDSS and COQ proteins and their roles in maintaining coenzyme Q
Yen HC; Yeh WY; Lee SH; Feng YH; Yang SL
Biochim Biophys Acta Bioenerg; 2020 Jul; 1861(7):148192. PubMed ID: 32194061
[TBL] [Abstract][Full Text] [Related]
14. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
16. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
17. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
18. Monomethyltransferase SET8 facilitates hepatocellular carcinoma growth by enhancing aerobic glycolysis.
Chen X; Ding X; Wu Q; Qi J; Zhu M; Miao C
Cell Death Dis; 2019 Apr; 10(4):312. PubMed ID: 30952833
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma.
Sun J; Li J; Guo Z; Sun L; Juan C; Zhou Y; Gu H; Yu Y; Hu Q; Kan Q; Yu Z
Oncol Res; 2019 Mar; 27(4):407-414. PubMed ID: 29444744
[TBL] [Abstract][Full Text] [Related]
20. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
